Federal Register - November 30, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
Federal Register / Vol. 86, No. 227 / Tuesday, November 30, 2021 / Rules and Regulations
68089
Table 12. Value ofCOVID-19 Risk Reductions Among Volunteers, 3% Discount Rate Value of Risk Impact
VSL orVSC 3%
Reduction
10.6
$11,501,365
$121,440,804
Mild Cases
414
$5,846
$2,422,527
Severe Cases
54.5
$13,104
$714,294
Critical Cases
1.2
$1,814,400
$2,176,442
Risk Reduction
Mortality Reductions Morbidity Reductions
Total Value of Risk Reductions
$126,754,066
Table 13. Value ofCOVID-19 Risk Reductions Among Volunteers, 7% Discount Rate Value of Risk Risk Reduction
Impact
VSL orVSC 7%
Reduction
Mortality Reductions
10.6
$11,501,365
$121,440,804
Mild Cases
414
$9,778
$4,051,467
Severe Cases
54.5
$22,176
$1,208,805
Critical Cases
1.2
$1,814,400
$2,176,442
Morbidity Reductions
Total Value of Risk Reductions
Summary of Monetized Benefits
discount rate. All estimates cover the time period between the publication of the interim final rule and March 1, 2022, and are reported in 2020 dollars. Table 15 reports the same estimates using a 7% discount rate.
ER30NO21.029
reductions to Head Start staff, mortality and morbidity risk reductions to Head Start volunteers, and time savings for parents and caregivers. These estimates cover both Head Start staff vaccination coverage scenarios, and correspond to VSC estimates using a 3%
VerDate Sep<11>2014
20:45 Nov 29, 2021
Jkt 256001
PO 00000
Frm 00039
Fmt 4701
Sfmt 4700
E:FRFM30NOR2.SGM
30NOR2
ER30NO21.028
lotter on DSK11XQN23PROD with RULES2
We identify several sources of monetized benefits that are attributable to the interim final rule. Table 14 reports the monetized benefits from mortality and morbidity risk
$128,877,518
